Australia, May 20 -- Dermagnostix R&D Gmbh, owns the trademark (2509920) for 'dermagnostix' till July 18, 2034.
Status: protected:
Registered/protected
Classes: 1 [Chemical testing for commercial and scientific purposes for detecting skin diseases, in particular for detecting skin diseases, predominantly consisting of chemical reagents, in particular containing oligonucleotides and/or antibodies for qualitatively and/or quantitatively determining the expression of biomarkers for detecting skin diseases, in particular for detecting psoriasis and/or atopic eczema and for distinguishing between psoriasis and atopic eczema.], 5 [Pharmaceuticals, in particular products for treating skin diseases, in particular for treating psoriasis and/or atopic eczema; diagnostic preparations for medical purposes, in particular in the field of dermatology, in particular in the field of diagnosing skin diseases, in particular for diagnosing dermato-oncological diseases or for diagnosing inflammatory skin diseases, in particular for diagnosing psoriasis and/or atopic eczema and for distinguishing between psoriasis and atopic eczema, in particular containing oligonucleotides and/or antibodies.] and 42 [Scientific and industrial research in particular in the biochemical, diagnostic or pharmaceutical fields; services provided by a biochemical or pharmaceutical laboratory, in particular in the field of dermatology, in particular in the field of diagnosing skin diseases, in particular for diagnosing dermato-oncological diseases or for diagnosing inflammatory skin diseases, in particular for diagnosing psoriasis and/or atopic eczema and for distinguishing between psoriasis and atopic eczema.]
Type of Mark: Word
Date of Acceptance: March 12
Registration Advertised: May 19
For further details contact Dentons Europe (Germany) Gmbh & Co. KG .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2509920.
Disclaimer: Curated by HT Syndication.
